Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry-Kravis

Showing results (31-40 of 265) with videos related to

Pageof 27
Sort By:
Brain and Cognition|December 31, 2019
Inhibition deficits are modulated by age and CGG repeat length in carriers of the FMR1 premutation allele who are mothers of children with fragile X syndromeJessica Klusek, Jinkuk Hong, Audra Sterling, et al.
Clinical Parkinsonism & Related Disorders|April 20, 2026
Essential tremor-like phenotype in Fragile X carrier womenDeborah A Hall, Danuta Loesch, Tyler Svymbersky, et al.
Movement Disorders Clinical Practice|February 5, 2019
BCAP31 Mutation Causing a Syndrome of Congenital Dystonia, Facial Dysorphism and Central Hypomyelination Discovered Using Exome SequencingPadmaja Vittal, Deborah A Hall, Shale Dames, et al.
Brain Sciences|December 20, 2018
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry PerspectiveAnna W Lee, Pamela Ventola, Dejan Budimirovic, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 27, 2020
TECPR2 mutation-associated respiratory dysregulation: more than central apneaPallavi P Patwari, Lisa F Wolfe, Girish D Sharma, et al.
Annals of Neurology|December 29, 2004
Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivationElizabeth Berry-Kravis, Kristina Potanos, Dahlia Weinberg, et al.
Archives of Neurology|August 18, 2004
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin systemJennifer G Goldman, Christopher G Goetz, Elizabeth Berry-Kravis, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 3, 2008
Early-phase ERK activation as a biomarker for metabolic status in fragile X syndromeNing Weng, Ivan Jeanne Weiler, Allison Sumis, et al.
Cerebellum (London, England)|August 24, 2015
Gait and Functional Mobility Deficits in Fragile X-Associated Tremor/Ataxia SyndromeJoan A O'Keefe, Erin E Robertson-Dick, Deborah A Hall, et al.
ACS Chemical Neuroscience|December 8, 2022
Emerging Therapeutic Strategies for Fragile X Syndrome: Q&AGhassan Alusi, Elizabeth Berry-Kravis, David Nelson, et al.
Pageof 27

Showing results (31-40 of 265) with videos related to

Sort By:
Pageof 27
Brain and Cognition|December 31, 2019
Inhibition deficits are modulated by age and CGG repeat length in carriers of the FMR1 premutation allele who are mothers of children with fragile X syndromeJessica Klusek, Jinkuk Hong, Audra Sterling, et al.
Clinical Parkinsonism & Related Disorders|April 20, 2026
Essential tremor-like phenotype in Fragile X carrier womenDeborah A Hall, Danuta Loesch, Tyler Svymbersky, et al.
Movement Disorders Clinical Practice|February 5, 2019
BCAP31 Mutation Causing a Syndrome of Congenital Dystonia, Facial Dysorphism and Central Hypomyelination Discovered Using Exome SequencingPadmaja Vittal, Deborah A Hall, Shale Dames, et al.
Brain Sciences|December 20, 2018
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry PerspectiveAnna W Lee, Pamela Ventola, Dejan Budimirovic, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 27, 2020
TECPR2 mutation-associated respiratory dysregulation: more than central apneaPallavi P Patwari, Lisa F Wolfe, Girish D Sharma, et al.
Annals of Neurology|December 29, 2004
Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivationElizabeth Berry-Kravis, Kristina Potanos, Dahlia Weinberg, et al.
Archives of Neurology|August 18, 2004
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin systemJennifer G Goldman, Christopher G Goetz, Elizabeth Berry-Kravis, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 3, 2008
Early-phase ERK activation as a biomarker for metabolic status in fragile X syndromeNing Weng, Ivan Jeanne Weiler, Allison Sumis, et al.
Cerebellum (London, England)|August 24, 2015
Gait and Functional Mobility Deficits in Fragile X-Associated Tremor/Ataxia SyndromeJoan A O'Keefe, Erin E Robertson-Dick, Deborah A Hall, et al.
ACS Chemical Neuroscience|December 8, 2022
Emerging Therapeutic Strategies for Fragile X Syndrome: Q&AGhassan Alusi, Elizabeth Berry-Kravis, David Nelson, et al.
Pageof 27